These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
621 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets containing N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled 268 Allura Xper FD20 Biplane systems on September 3, 2025. The recall affects units distributed globally due to potential failures in internal components. If malfunction occurs, motorized movements will be disabled, posing risks to operational efficiency.
Philips Medical Systems recalled 2,114 Allura Xper FD20 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, risking loss of motorized functionality. This recall affects 791 units in the U.S. and 1,323 globally.
Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets exceed the acceptable limit for N-Nitroso Desmethyl Chlorpromazine. This recall affects the nationwide distribution in the USA.
Philips Medical Systems recalled 298 Allura Xper FD20 operating room tables on September 3, 2025, due to a faulty BIOS battery. The battery depletes faster than expected, halting system start-up without warning. This recall affects 72 units in the U.S. and 226 units distributed internationally.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10C model on September 3, 2025, due to a potential BIOS battery issue. The battery may deplete faster than expected, halting system startup without warning. Only two units are affected in the U.S.
Philips Medical Systems recalled 585 Allura Xper FD10/10 imaging systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting system start-up. This affects models 722005, 722011, and 722027 distributed worldwide.
New Spirit Naturals recalled 178 units of Super Muscle Support Powder on September 3, 2025. The product contains an undeclared allergen, milk, posing a serious health risk. Consumers should stop using the product immediately and contact the company for a refund.
Beckman Coulter recalled 2,146 units of SYNCHRON Systems Phosphorus reagents on September 3, 2025. The affected lots may fail calibration before expiration, delaying patient results. Healthcare providers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled 115 Allura Xper FD20/20 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system during startup. The recall affects 34 devices in the U.S. and 81 internationally.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20 Biplane OR Table on September 3, 2025, due to a potential BIOS battery failure. The recall affects four units distributed globally, including two in the U.S. and two internationally.
Inpeco S.A. recalled eight units of its FlexLab (FLX) Potassium Test System on September 3, 2025. The system's Sample Integrity Module may produce erroneous results due to unverified functions. Healthcare providers must stop using the device immediately and follow the manufacturer's instructions.
Philips Medical Systems Nederland B.V. recalled 5,067 Allura Xper FD20 devices on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This issue affects models 722006, 722012, and 722028 and poses a high risk to patient safety.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10 Operating Room Table on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process. This recall affects two units distributed worldwide, including the U.S. and multiple countries.
Inpeco S.A. recalled one unit of the FlexLab X (FXX) System on September 3, 2025. The recall affects the Sample Integrity Module, which has not been FDA evaluated for safety. This may cause erroneous results or delays in patient testing.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/20 operating room table on September 3, 2025, due to a potential BIOS battery failure. The battery may deplete faster than expected, causing the system to halt without warning. This recall affects five units distributed worldwide.
Philips Medical Systems recalled 501 Allura Xper FD20 Biplane systems on September 3, 2025. The BIOS battery may deplete quickly, halting system startup without warning. The recall affects devices distributed worldwide, including the US and several countries in Europe and Asia.